No abstract

Background: Several factors contribute to the increased use of herbal products: namely, easy accessibility, perception of herbs as safe alternate treatment, desire for self-medication, and lesser cost. With expanding utilization of home-grown medications, there have been concerns with respect to the security of these items, specifically the potential communication of these medications with regular medications. Certain natural enhancements can cause conceivably perilous symptoms when taken with physician recommended drugs.Objective: To inspect the pharmacodynamic interaction of allicin and gliclazide in animal models and to understand the safety and adequacy.Methods: Single and multiple dose treatments in normal rats, diabetes triggered rats and rabbits to assess the impact of allicin on the gliclazide movement. Blood tests from the examination of animals were utilized for the estimation insulin and glucose levels by utilizing radioimmunoassay technique and science analyzer (computerized) separately. Homeostasis evaluation utilized for assurance of β-cell work.Results: Gliclazide produces huge lessening in blood glucose levels in diabetic animals. In the combination, gliclazide in mix with allicin demonstrated more noticeable diminishment in blood glucose fixation in animals with diabetes. Conclusion:Coadministration of allicin and gliclazide did enhance the antidiabetic activity compared with individual drugs.

Back Ground:The objective of the present study was to find out the pharmacodynamic and pharmacokinetic interactions of piperine on gliclazide in rats and rabbits. Methods: Influence of piperine on the activity of gliclazide was determined by conducting single-and multipledose interaction studies in rats (normal and diabetic) and diabetic rabbits. Blood samples collected at predetermined time intervals from experimental animals were used for the estimation of glucose and insulin levels by using automated clinical chemistry analyzer and radioimmunoassay method, respectively. β-cell function was determined by homeostasis model assessment. Additionally, serum gliclazide levels in rabbits were analyzed by highperformance liquid chromatography. Results: Gliclazide showed significant reduction in blood glucose levels in diabetic rats and rabbits. Similarly, piperine also showed significant reduction in blood glucose levels in animals. Additionally, , samples analyzed from all time points in combination with piperine showed peak reduction in blood glucose in diabetic rats and rabbits. The pharmacokinetics of gliclazide was also altered by single-or multiple-dose piperine treatments in rabbits. Conclusion: The interaction of piperine with gliclazide upon single and multiple-dose treatment was pharmacodynamic and pharmacokinetic in nature, indicating the need for periodic monitoring of glucose levels and dose adjustment as necessary when this combination is prescribed to diabetic patients.